# Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

> **NCT02389946** · NA · COMPLETED · sponsor: **Biotronik, Inc.** · enrollment: 1334 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis, Coronary
- Myocardial Ischemia
- Ischemic Heart Disease
- Acute Coronary Syndrome
- Angina Pectoris

## Interventions

- **DEVICE:** Orsiro DES
- **DEVICE:** Xience DES

## Key facts

- **NCT ID:** NCT02389946
- **Lead sponsor:** Biotronik, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-04
- **Final completion:** 2021-03
- **Target enrollment:** 1334 (ACTUAL)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389946, "Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02389946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*